DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Neurologic-agent are 13

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_0435	Lomerizine	Neurologic-agent	Migraine disorders	Ebola virus	eGFP-EBOV	NA	Fluorescence-based assay	Decrease (50 %)	Experimental	26041706
DrugRepV_0462	Lomerizine	Neurologic-agent	Migraine disorders	Ebola virus	eGFP-EBOV	NA	Fluorescence-based assay	Decrease (50 %)	Experimental	26041706
DrugRepV_0491	Lomerizine	Neurologic-agent	Migraine disorders	Ebola virus	EBOV-VLP	NA	Flow cytometry	Decrease (>90 %)	Experimental	26041706
DrugRepV_1193	Carbidopa	Neurologic-agent	Parkinson Disease	Zika virus	MEX_I_7	NA	Fluorescence-based assay	Decrease (51.045 %)	Approved	27476412
DrugRepV_1674	SIB 1893	Neurologic-agent	Epilepsy	Zika virus	MR766	NA	Cell viability assay	No significant effect (0 %)	NA	27571349
DrugRepV_1745	SIB 1893	Neurologic-agent	Epilepsy	Zika virus	MR766	NA	Cell viability assay	No significant effect (0 %)	NA	27571349
DrugRepV_1816	SIB 1893	Neurologic-agent	Epilepsy	Zika virus	MR766	NA	Cell viability assay	No significant effect (0 %)	NA	27571349
DrugRepV_2359	Nefiracetam	Neurologic-agent	Alzheimer's Disease	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	No significant decrease (2.954445 %)	Investigational	27742486
DrugRepV_2526	Edaravone	Neurologic-agent	Amyotrophic lateral scleorosis	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-0.4295646 %)	Approved	27742486
DrugRepV_2680	Carbidopa	Neurologic-agent	Parkinson Disease	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-2.5784382 %)	Approved	27742486
DrugRepV_2729	Creatinine	Neurologic-agent	Amyotrophic Lateral Sclerosis	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-3.4231528 %)	Investigational	27742486
DrugRepV_2736	Benserazide	Neurologic-agent	Parkinson's disease	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-3.5576471 %)	Approved	27742486
DrugRepV_2876	Blonanserin	Neurologic-agent	Schizophrenia	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-8.1057248 %)	Investigational	27742486